Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
deferoxamine (desferal) (1 trial)
Brain Ischemia (Phase 1)
Cerebral Infarction (Phase 1)
Hemorrhage (Phase 1)
Ischemia (Phase 1)
Subarachnoid Hemorrhage (Phase 1)
Trials (1 total)
Trial APIs (1 total)